COVID-19 and Immunomodulatory Therapy — Can We Use Data from Previous Viral Pandemics?

One Semester of Occupational Therapy Passed Virtually: What Experiences Did We Learn from Covid-19?

One Semester of Occupational Therapy Passed Virtually: What Experiences Did We Learn from Covid-19?  Masoud Gharib 1, Seyed Ali Hosseini 2     1 Assistant Professor, Department of Occupational, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran 2 Professor, Department of Occupational Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran...

COVID-19 Control: Can Germany Learn From China?

The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an early stage. The epicentre of the pandemic has since shifted to Europe a...

What can we learn from time-use data?

T he study of economics often is concerned with optimal decisionmaking in the face of some sort of constraint. Economist Thomas Juster has argued that the ultimate constraint on human activity is time. We are each given 24 hours per day to devote to competing uses, and how we use that time has important implications for our financial security, health, emotional well-being, and general level of ...

viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

context several risk factors play the role in the development of hepatocellular carcinoma (hcc) from which chronic hepatitis b and c infections are the most important ones. dna integration of hepatitis viruses alters the function of critical genes promoting malignant transformation of virus-infected liver cells. evidence acquisition there are remarkable geographic differences in prevalence of c...

The Battle Against COVID-19: Where Do We Stand Now?